Boehringer signs $1.3B MASH collab with RNA biotech Ochre fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Boehringer Ingelheim, Ochre Bio Launch Up-to-$1B+ Liver Disease Partnership genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
The increasing trend in strategic partnerships between innovator companies, and the US FDA approval for Rezdiffra has led to a boost in the development of medications for MASH.
Medicinal Chemistry Summer School 2024 rsc.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rsc.org Daily Mail and Mail on Sunday newspapers.
Boehringer Ingelheim has paid $27.3 million upfront to Sosei Heptares to develop a small molecule agonist of GPR52 to treat the positive, negative and cognitive symptoms of schizophrenia.